Developer of rapid diagnostic tests used to detect infectious diseases at the point of care, primarily through its Dual Path Platform (DPP) lateral flow technology. The company’s products have targeted conditions such as HIV, COVID‑19, and other global health threats, with customers that have includ...
This page tracks all publicly disclosed congressional trades in Chembio Diagnostics, Inc. (CEMI), a company in the Healthcare sector. 1 member of Congress has disclosed trades in this stock, including 3 purchases and 2 sales. All data is sourced from STOCK Act Periodic Transaction Reports filed with the House and Senate disclosure offices.
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2014-10-27 | Chris Collins | sell | $100K – $250K |
| 2014-10-14 | Chris Collins | sell | $1K – $15K |
| 2014-05-09 | Chris Collins | buy | $100K – $250K |
| 2014-05-09 | Chris Collins | buy | $15K – $50K |
| 2014-05-07 | Chris Collins | buy | $50K – $100K |